Literature DB >> 24411403

Mutations and polymorphisms in N-acetylgalactosamine-6-sulfate sulfatase gene in Turkish Morquio A patients.

S Khedhiri1, L Chkioua2, N Elcioglu3, S Laradi4, A Miled2.   

Abstract

Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive inherited metabolic disease resulting from deficiency of N-acetylgalactosamine-6-sulfatase (GALNS). This lysosomal storage disorder leads to a wide range of clinical variability ranging from severe, through intermediate to mild forms. The classical phenotype of Morquio A disease is characterized by severe bone dysplasia without intellectual impairment. Two severe MPS IVA patients from two unrelated Turkish families have been investigated. The 14 exons and intron-exon junctions of the GALNS gene were sequenced after amplification from genomic DNA. Direct sequencing revealed two homozygous mutations previously described: p.L390X in exon 11 and p.W141R in exon 4. The p L390X mutation was associated with four novel polymorphisms in intron 2, intron 5 and intron 6 and one polymorphism previously described in exon 7. We have analysed the haplotypes associated with the two identified mutations. These molecular findings will permit accurate carrier detection, prenatal diagnosis and counseling for Morquio A syndrome in Turkey.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Consanguinity; Consanguinité; GALNS; Mucopolysaccharidose de type IVA; Mucopolysaccharidosis type IVA; Mutations; Polymorphisme; Polymorphisms

Mesh:

Substances:

Year:  2014        PMID: 24411403     DOI: 10.1016/j.patbio.2013.10.001

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

Review 1.  Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants.

Authors:  Alessandra Zanetti; Francesca D'Avanzo; Moeenaldeen AlSayed; Ana Carolina Brusius-Facchin; Yin-Hsiu Chien; Roberto Giugliani; Emanuela Izzo; David C Kasper; Hsiang-Yu Lin; Shuan-Pei Lin; Laura Pollard; Akashdeep Singh; Rodolfo Tonin; Tim Wood; Amelia Morrone; Rosella Tomanin
Journal:  Hum Mutat       Date:  2021-08-23       Impact factor: 4.700

2.  Morquio A syndrome and effect of enzyme replacement therapy in different age groups of Turkish patients: a case series.

Authors:  Sebile Kılavuz; Sibel Basaran; Deniz Kor; Fatma Derya Bulut; Sevcan Erdem; Hüseyin Tuğsan Ballı; Muhammed Dağkıran; Atil Bisgin; Halise Neslihan Önenli Mungan
Journal:  Orphanet J Rare Dis       Date:  2021-03-22       Impact factor: 4.123

3.  Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities.

Authors:  Yana Puckett; Alejandra Mallorga-Hernández; Adriana M Montaño
Journal:  Orphanet J Rare Dis       Date:  2021-05-29       Impact factor: 4.123

4.  Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation.

Authors:  Latifa Chkioua; Souhir Khedhiri; Hind Hafsi; Oussama Grissa; Hadhami Ben Turkia; Abdelhedi Miled; Sandrine Laradi; Roseline Froissart; Najat Alif
Journal:  Diagn Pathol       Date:  2016-06-17       Impact factor: 2.644

5.  Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity.

Authors:  Sedigheh Shams; Maliheh Barazandeh Tehrani; Gabriel Civallero; Koosha Minookherad; Roberto Giugliani; Aria Setoodeh; Mohammad Taghi Haghi Ashtiani
Journal:  J Diabetes Metab Disord       Date:  2017-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.